Keith Katkin Insider Trading $RIGL RIGEL PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Keith Katkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Keith Katkin. Keith Katkin is Sr. V.P. of Sales & Marketing in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Carbylan Therapeutics, Inc. ($CBYL) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in Novus Therapeutics, Inc. ($NVUS) and PEO;CEO-Urovant Sciences,Inc. in Urovant Sciences Ltd. ($UROV) and PEO;CEO/Urovant Sciences, Inc. in Urovant Sciences Ltd. ($UROV).
Keith Katkin in RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 15 2020
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Keith Katkin in RIGEL PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVNR, ELDN, KALV, RIGL, SNDX, UROV
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
| May 15 2020 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 1.77 | 55,000 | 97,075 | 55,000 | |
| May 24 2019 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 2.02 | 55,000 | 111,100 | 55,000 | |
| May 18 2018 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 3.98 | 40,000 | 159,200 | 40,000 | |
| May 12 2017 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 2.61 | 40,000 | 104,400 | 40,000 | |
| May 12 2016 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 2.40 | 40,000 | 96,000 | 40,000 | |
| Jul 01 2015 | RIGL | RIGEL PHARMACEUTIC ... | Katkin Keith | Director | Option Exercise | A | 3.26 | 80,000 | 260,800 | 80,000 |
Page: 1